Empagliflozin in Post AKI Stage 2-3
1 clinical trials · Condition
◉ Watch Empagliflozin in Post AKI Stage 2-3
| Record | Firm | Date |
|---|---|---|
| The Effects of Empagliflozin on Renal Outcomes in Post Severe Acute Kidney Injury Survivors (NCT05360615) | Chulalongkorn University | 2022-07-01 |
Track Empagliflozin in Post AKI Stage 2-3 automatically
Every clearance here is in the API, with alerts when new ones post.